Yumi Itoh Selected Research

pterosin B

3/2016	Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3.
1/2016	Corrigendum: Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3.
7/2015	Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumi Itoh Research Topics

Disease

2	Hepatitis B 04/2022 - 03/2021
2	Infections 04/2022 - 01/2022
2	Hypertrophy 03/2016 - 01/2016
2	Osteoarthritis 03/2016 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2016 - 01/2011
1	Disease Progression 01/2022
1	COVID-19 01/2022
1	Ischemia 12/2018
1	Hypoxia (Hypoxemia) 12/2018
1	Reperfusion Injury 12/2018
1	Colitis 01/2016
1	Crohn Disease (Crohn's Disease) 01/2016
1	Diarrhea 01/2016
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 07/2015
1	Septic Shock (Toxic Shock Syndrome) 06/2015
1	Alzheimer Disease (Alzheimer's Disease) 12/2014
1	Myocardial Infarction 08/2012
1	Heart Failure 08/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012
1	Insulin Resistance 08/2012
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2012
1	Experimental Melanoma 12/2010

Drug/Important Bio-Agent (IBA)

3	pterosin BIBA 03/2016 - 07/2015
3	SaltsIBA 03/2016 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 03/2021
2	LipopolysaccharidesIBA 12/2018 - 06/2015
2	carnosolIBA 12/2018 - 01/2016
2	Phosphotransferases (Kinase)IBA 03/2016 - 06/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2011 - 12/2010
1	hepatitis B hyperimmune globulinIBA 04/2022
1	Amino Acids FDA Link 04/2022
1	AntibodiesIBA 04/2022
1	Monoclonal AntibodiesIBA 04/2022
1	Immunoglobulins (Immunoglobulin)IBA 04/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Melanins (Melanin)IBA 01/2016
1	Dextran SulfateIBA 01/2016
1	Nonsense Codon (Nonsense Mutation)IBA 01/2016
1	Microphthalmia-Associated Transcription FactorIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 07/2015
1	Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)IBA 07/2015
1	GlycogenIBA 07/2015
1	Pharmaceutical PreparationsIBA 12/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2014
1	N-Methylaspartate (NMDA)IBA 12/2014
1	Memantine (Namenda)FDA Link 12/2014
1	Triglycerides (Triacylglycerol)IBA 08/2012
1	Uric Acid (Urate)IBA 08/2012
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2012
1	AdiponectinIBA 08/2012
1	HDL CholesterolIBA 08/2012
1	Alitretinoin FDA Link 01/2012
1	3,3',7-trihydroxy-4'-methoxyflavonIBA 01/2011
1	fisetinIBA 01/2011

Therapy/Procedure

2	Therapeutics 04/2022 - 01/2022
1	Intra-Articular Injections 03/2016